Chauhan Shivkumar D, Nath Nirmalendu M, Tule Vinay K
Eugeniks, Genetic Research Institute, 106/A-wing, First floor, Lokmat Bhavan, Ramdaspeth, Nagpur-440 012, (MS), India.
Int J Diabetes Dev Ctries. 2009 Jan;29(1):23-7. doi: 10.4103/0973-3930.50711.
Earlier, we had found high levels of circulating immune complexes (CICs) in the serum of type 2 diabetes mellitus patients along with a novel 43 kDa protein.
Different tissues of alloxan-induced, diabetic, male albino rats (200-250 g in body weight) were collected for the present study. Tissue proteins were isolated and separated by 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE). A primary cell culture of polymorphonuclear neutrophils (PMNs) was used to evaluate the effects of the diabetogenic protein. Cell proliferative index, oxidant/antioxidant status, and ion-transporting ability were chosen as study parameters.
SDS-PAGE of different tissues shows that the diabetic liver alone was the only tissue that contained the 43 kDa protein band compared to the normal liver. In vitro effects of the new liver protein on PMNs include significantly decreased cell proliferative activity, increased free radical levels, and decreased levels of antioxidant enzymes as well as ionic transporters. The new liver protein also exhibited protease activity when compared with standard trypsin.
This study concluded that a novel 43 kDa protein obtained from the livers of alloxan-induced diabetic rats shows protease activity as well as antiproliferative activity. Also, this protein may act as a diabetogenic factor as it elicited a significantly gross elevation in the oxidant status level as well as in the levels of lysosomal enzymes and a decrease in the levels of antioxidative enzymes and ionic transporters of PMNs.
此前,我们发现2型糖尿病患者血清中循环免疫复合物(CICs)水平较高,同时还有一种新的43 kDa蛋白。
本研究收集了用四氧嘧啶诱导的糖尿病雄性白化大鼠(体重200 - 250克)的不同组织。分离组织蛋白并通过10%十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳(SDS - PAGE)进行分离。使用多形核中性粒细胞(PMN)的原代细胞培养来评估致糖尿病蛋白的作用。选择细胞增殖指数、氧化/抗氧化状态和离子转运能力作为研究参数。
不同组织的SDS - PAGE显示,与正常肝脏相比,仅糖尿病肝脏是含有43 kDa蛋白条带的唯一组织。新的肝脏蛋白对PMN的体外作用包括细胞增殖活性显著降低、自由基水平升高、抗氧化酶水平降低以及离子转运蛋白水平降低。与标准胰蛋白酶相比,新的肝脏蛋白还表现出蛋白酶活性。
本研究得出结论,从四氧嘧啶诱导的糖尿病大鼠肝脏中获得的一种新的43 kDa蛋白具有蛋白酶活性和抗增殖活性。此外,这种蛋白可能作为一种致糖尿病因子,因为它导致氧化状态水平以及溶酶体酶水平显著大幅升高,同时PMN的抗氧化酶和离子转运蛋白水平降低。